This poster presents results of an analysis of trends in review publications: the authors analyzed the publication of review articles for drugs receiving US FDA marketing approval in 2009 (n=26) and 2013 (n=29).

This poster was presented by representatives of the Cactus Life Sciences team at the 11th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP), 2015.

Write to us to get a personal copy of the poster pdf.

About the author

Cactus Life Sciences
+ posts

Cactus Life Sciences is a medical communication company that provides scientific strategy and content across the healthcare continuum, anywhere in the world ─ with a focus on science, innovation, and efficiency. We work alongside leading healthcare companies to establish the optimal role of medicines and encourage positive behaviors (physician and patient) that improve patient outcomes.